Search

everythinglearnresearchcommunity

for

Search:↓

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Dermoscopy has greatly improved the diagnosis of skin lesions and our understanding of their morphology and biology.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

A man with nevus comedonicus syndrome had multiple skin issues, including basal cell carcinomas, which improved with treatment.

M1 homeopathic complex may help slow melanoma cell growth.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Childhood cancer survivors need better skin care and sun protection.

Melanin may help melanoma cells grow by aiding their metabolism.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

An 86-year-old man had a rare tongue melanoma but refused treatment, showing the need for early cancer detection and treatment.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

Finding a positive nonsentinel lymph node in melanoma patients indicates a worse prognosis.

Human melanocytes have unique traits that affect melanoma development and prognosis.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.